A study of 188 AIS patients and 90 stroke mimics reported on a biomarker panel including IL-6, S100B, and MMP-9 which was incorporated in a clinical data assessment (age, AF, Face-Arm-Speech-Test results). This evidence concerns the gene MMP9 and atrial fibrillation.